Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Ratios

Wave Life Sciences (WVE) Non-cash Items (2016)

Wave Life Sciences (WVE) has disclosed Non-cash Items for 2 consecutive years, with $997146.0 as the latest value for Q2 2016.

For Q2 2016, Non-cash Items changed N/A year-over-year to $997146.0; the TTM value through Jun 2016 reached $997146.0, changed N/A, while the annual FY2015 figure was $3.8 million, N/A changed from the prior year.
Non-cash Items hit $997146.0 in Q2 2016 for Wave Life Sciences, up from $848223.0 in the prior quarter.
Across five years, Non-cash Items topped out at $75.1 million in Q3 2015 and bottomed at $848223.0 in Q1 2016.